Risk factors and mechanisms of non-alcoholic steatohepatitis
- PMID: 18667295
- PMCID: PMC2600439
- DOI: 10.1016/j.pathophys.2008.04.003
Risk factors and mechanisms of non-alcoholic steatohepatitis
Abstract
The worldwide proportion of overweight and obese individuals has increased yearly for more than a decade. Along with rates of obesity, the incidence of co-morbid conditions such as type 2 diabetes, cardiovascular disease and liver disease has also increased. The form of liver disease associated with obesity is termed non-alcoholic steatohepatitis (NASH) due to the histological similarities to livers of chronic alcoholics. NASH has been observed in adult as well as pediatric populations; however, the etiology of this disease is still unknown. This review outlines some of the risk factors commonly associated with NASH and describes molecular mechanisms proposed to underlie disease pathogenesis.
Figures

Similar articles
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
-
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36400097
-
The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.JHEP Rep. 2022 Jun 15;4(9):100525. doi: 10.1016/j.jhepr.2022.100525. eCollection 2022 Sep. JHEP Rep. 2022. PMID: 36039144 Free PMC article.
-
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.Diabetes Metab. 2022 Sep;48(5):101363. doi: 10.1016/j.diabet.2022.101363. Epub 2022 Jun 24. Diabetes Metab. 2022. PMID: 35760372
-
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.J Hepatol. 2019 Aug;71(2):313-322. doi: 10.1016/j.jhep.2019.04.011. Epub 2019 May 7. J Hepatol. 2019. PMID: 31071367 Free PMC article.
Cited by
-
Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.Obes Surg. 2010 May;20(5):640-50. doi: 10.1007/s11695-010-0078-2. Epub 2010 Jan 30. Obes Surg. 2010. PMID: 20119733
-
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.PLoS One. 2014 Jan 3;9(1):e83819. doi: 10.1371/journal.pone.0083819. eCollection 2014. PLoS One. 2014. PMID: 24404139 Free PMC article.
-
Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects.J Am Heart Assoc. 2021 Jul 20;10(14):e021430. doi: 10.1161/JAHA.121.021430. Epub 2021 Jul 14. J Am Heart Assoc. 2021. PMID: 34259033 Free PMC article.
-
Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.Hypertens Res. 2021 Sep;44(9):1213-1220. doi: 10.1038/s41440-021-00679-1. Epub 2021 Jun 11. Hypertens Res. 2021. PMID: 34117403
-
Germacrone cooperates with dexmedetomidine to alleviate high-fat diet-induced type 2 diabetes mellitus via upregulating AMPKα1 expression.Exp Ther Med. 2019 Nov;18(5):3514-3524. doi: 10.3892/etm.2019.7990. Epub 2019 Sep 9. Exp Ther Med. 2019. Retraction in: Exp Ther Med. 2024 Jan 29;27(3):119. doi: 10.3892/etm.2024.12406. PMID: 31602228 Free PMC article. Retracted.
References
-
- Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007;22:293–303. - PubMed
-
- Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48–53. - PubMed
-
- McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002;34:255–262. - PubMed
-
- Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002;288:1728–1732. - PubMed
-
- Harnois F, Msika S, Sabate JM, Mechler C, Jouet P, Barge J, Coffin B. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2006;16:183–188. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources